NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SFA Therapeutics

SFA Therapeutics

Private
Jenkintown, PennsylvaniaHealthcare & Life Scienceshttps://sfatherapeutics.com/

Last Round

Series A

Mar 13, 2025

Est. Valuation

$250M

Total Funding Raised

$4.23M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

SFA Therapeutics is a clinical-stage biopharmaceutical company that develops oral, small-molecule therapeutics for autoimmune diseases, chronic inflammatory diseases, and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule drugsanti-inflammatory therapeuticsdrug discoveryclinical-stage biotechoral therapeuticsinflammatory bowel diseasepsoriasis treatmentdrug licensingbiotech startupnon-biologic drugsclinical trialspharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SFA Therapeutics Comps

Public and private peers based on sector, stage, and business model.

SFA Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SFA Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 13, 2025
VC RoundNov 9, 2023
SeedJun 20, 2022
AcceleratorSep 2, 2021
GrantJun 24, 2020
Seed
Jul 31, 2018

Key People

Founding team and executive leadership

Alla Arzumanyan

CDO, Co-founder And Co-inventor, SFA Therapeutics, Inc.

Founding Team

Ira Spector

CEO

Executive Team

Robert Dickey

Member, Board Of Directors, Chief Financial Officer

Executive Team

James Kirwin

COO And Sr VP, Clinical Development

Executive Team

SFA Therapeutics Investors

Notable investors and investment history

SFA Therapeutics investors
InvestorRounds
INP CapitalSeed
Benjamin Franklin Technology PartnersSeed, VC Round, Grant
Acequia CapitalSeed
Asymmetry VenturesSeed, VC Round
Y CombinatorAccelerator
Montgomery County, PennsylvaniaSeed, VC Round, Grant
Boost VCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 44% MoM.

  • Mar 7, 2025

    Presented data for oral psoriasis drug candidate SFA-002 at dermatology conference.

SFA Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SFA Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SFA Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersJenkintown, Pennsylvania
Employee Range9
Year Founded2016
Last FundingMar 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.